ClinConnect ClinConnect Logo
Search / Trial NCT06986577

Effect of Mechanical Ventilation on Cardiac RF Ablation

Launched by IZMIR CITY HOSPITAL · May 15, 2025

Trial Information

Current as of September 08, 2025

Not yet recruiting

Keywords

Mechanical Ventilation Cardiac Radiofrequency Ablation Pediatric Arryhtmia

ClinConnect Summary

This clinical trial is looking at how different methods of breathing support, called mechanical ventilation, might affect a heart procedure known as radiofrequency catheter ablation in children. The main focus is to see if using a technique with lower air volume helps make the ablation more successful and to understand how it impacts the effectiveness of the procedure, the time it takes, and if heart rhythm problems come back within the first month after the procedure.

To participate in this study, children aged between 0 and 18 years who have undergone recent heart surgery at Izmir City Hospital may be eligible. However, some children may not qualify if they have certain conditions, like previous heart surgeries or specific health issues that could complicate their care. If eligible, participants can expect to be closely monitored during the procedure, and researchers will track various outcomes to gather valuable information that could improve treatments in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Between 0-18 years
  • Paediatric surgery under general anaesthesia at Izmir City Hospital in the last 3 months since the date undergoing cardiac radiofrequency ablation procedure
  • Procedures were performed with catheters with contract force measurement feature patients with
  • Exclusion Criteria:
  • Patients with maintenance other than inhalation anaesthesia
  • Patients whose anaesthesia method is changed during the procedure
  • Patients with airway complications
  • Development of haemodynamic instability during the procedure
  • Patient with a history of previous cardiac surgery
  • Presence of additional cardiac disease, advanced connective tissue disease, connective tissue disease, mitochondrial muscle disease

About Izmir City Hospital

Izmir City Hospital is a leading healthcare institution in Turkey, dedicated to advancing medical research and patient care through innovative clinical trials. As a prominent sponsor of clinical studies, the hospital focuses on a wide range of therapeutic areas, aiming to enhance treatment options and improve health outcomes. With a commitment to ethical standards and patient safety, Izmir City Hospital collaborates with experienced researchers and healthcare professionals to ensure rigorous study design and implementation. The facility is equipped with state-of-the-art technology and resources, fostering an environment that promotes scientific inquiry and the translation of research findings into clinical practice.

Locations

Patients applied

0 patients applied

Trial Officials

Gözde Gürsoy Çirkinoğlu, MD

Principal Investigator

Izmir City Hospital, Anesthesiology and Reanimation Department

Halide Hande Sahinkaya, MD

Study Chair

Izmir City Hospital, Anesthesiology and Reanimation Department

Zeki Tuncel Tekgül, Prof. Dr.

Study Chair

University of Health Sciences, Izmir City Hospital, Anesthesiology and Reanimation Department

Cem Karadeniz, Prof. Dr

Study Chair

Izmir Katip Celebi University Medical Faculty, Pediatric Cardiology Department

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported